Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The peptide prompts rapid activation of collateral vascular pathways, particularly the azygos vein system, enabling direct blood flow delivery that bypasses occluded vessels
For step-by-step preparation and stock-solution arithmetic, see the guide on reconstituting research peptides with bacteriostatic water and the accompanying concentration & volume calculator walkthrough
Investigating the effect of microvesicle on stemness potential of mesenchymal stem cells was performed for safety concerns
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties
US$ 25.81
US$ 27.87
US$ 25.50
US$ 22.97
US$ 20.82
